Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema

Retina

Volumn 30, Issue 10, 2010, Pages 1638-1645

  Solaiman, Kamal A M ^a   Diab, Mohammad M ^b   Abo Elenin, Mostafa ^c  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c TANTA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; EYE EXAMINATION; FEMALE; HUMAN; LASER COAGULATION; MALE; MODIFIED GRID LASER PHOTOCOAGULATION; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA SURGERY; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAVITREAL INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 78650179842     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181e1ed07     Document Type: Article

References (21)

1. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology 1984;91:1-9.
2. Hee MR, Puliafito CA, Duker JS, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998;105:360-370.
3. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-1806.
4. Bandello F, Lanzetta P, Menchini U. When and how to do a grid laser for diabetic macular edema. Doc Ophthalmol 1999;97: 415-419.
5. Figueroa MS, Contreras I, Noval S. Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema. Retina 2008;28: 420-426.
6. Scott IU, Danis RP, Bressler SB, et al. Effect of focal/grid photocoagulation on visual acuity and retinal thickening in eyes with non-center-involved diabetic macular edema. Retina 2009;29:613-617.
7. Lee CM, Olk RJ. Modified laser grid photocoagulation for diffuse macular edema. Long term visual results. Ophthalmology 1991;98:1594-1602.
8. Olk RJ. Modified grid argon (blue-green) laser photocoagula-tion for diffuse diabetic macular edema. Ophthalmology 1986; 93:938-950.
9. Audren F, Lecleire-Collet A, Erginay A, et al. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg. Am J Ophthalmol 2006; 142:794-799.
10. Haritoglou C, Kook D, Neubauer A, et al. Intravitreal bevaci-zumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006;26:999-1005.
11. Lam DSC, Lai TYY, Lee VYW, et al. Efficacy of 1.25 mg versus 2.5 mg intravitreal bevacizumab for diabetic macular edema. Six-month results of a randomized controlled trial. Retina 2009;29:292-299.
12. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L, Maia M, Berrocal MH, Solis-Vivanco A, Farah ME, for the Pan-american Collaborative Retina Study Group. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema. Ophthalmology 2007;114:743-750.
13. Christos H, Daniel K, Aljoscha N, et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006;26:999-1005.
14. Soheilian M, Ramezani A, Bijanzadeh B, et al. Intravitreal bevacizumab (Avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Retina 2007;27:1187-1195.
15. Diabetic Retinopathy Clinical Research Network. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 2007;114:525-536.
16. Schmid KE, Neumaier-Ammerer B, Stolba U, Binder S. Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin (HbA1c). Graefes Arch Clin Exp Ophthalmol 2006;244:1446-1452.
17. Avery RA, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695-1705.
18. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006;26:275-278.
19. Kang SW, Sa HS, Cho HY, Kim JI. Macular grid photoco-agulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema. Arch Ophthalmol 2006;124:653-658.
20. Lam DSC, Chan CKM, Mohamed S, et al. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema. Six-month outcomes. Ophthalmology 2007;114:2162-2167.
21. Weiter JJ, Zuckerman R. The influence of photoreceptor-RPE complex on the inner retina; an explanation for beneficial effects of photocoagulation. Ophthalmology 1980;87:1133-1139.